Eleven-Nineteen-Leukemia Protein IN-3;2-Phenanthridinecarboxamide, 5,6-dihydro-5-methyl-N-[2-[[(2S)-2-methyl-1-pyrrolidinyl]methyl]-1H-benzimidazol-6-yl]-6-oxo-
Eleven-Nineteen-Leukemia Protein IN-3 is an orally effective ENL YEATS domain inhibitor (IC50 = 15.4 nM) that downregulates MYC expression via ENL in cells and enhances the thermal stability of ENL protein in vitro.